View Older Stories View More Recent Stories

Jan 19, 2024 12:02PM Form SC 13G/A Bitcoin Depot Inc. Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Jan 19, 2024 12:02PM Form SC 13G/A Healthcare AI Acquisitio Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Jan 19, 2024 12:01PM Form SC 13G/A Generation Asia I Acquis Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Jan 19, 2024 12:01PM Form SC 13G/A Global Blockchain Acquis Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Jan 19, 2024 12:00PM Form SC 13G/A DP Cap Acquisition Corp Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Jan 12, 2024 04:15PM Form 4 HH&L Acquisition Co. For: Jan 10 Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Jan 3, 2024 04:16PM Form 4 KnightSwan Acquisition For: Dec 06 Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Jan 3, 2024 04:15PM Form SC 13G/A KnightSwan Acquisition Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Dec 18, 2023 08:02AM Biora Therapeutics (BIOR) Accelerates Debt Reduction and Raises Capital
Dec 18, 2023 08:00AM Biora Therapeutics Accelerates Debt Reduction and Raises Capital with Large Institutional Investors
Nov 17, 2023 09:00AM The J.M. Kaplan Fund Names Julia Bator as New Executive Director
Nov 13, 2023 12:03PM Form 13F-HR HIGHBRIDGE CAPITAL MANAG For: Sep 30
Nov 8, 2023 07:00AM Veritone Reports Third Quarter 2023 Results
Oct 17, 2023 12:52PM SYMETRYX SEEKS TO CHANGE BOARD AND MAXIMIZE SHAREHOLDER VALUE
Sep 29, 2023 07:36AM Capricor Therapeutics (CAPR) Announces 4.94M Share Offering at $4.66/sh
Sep 29, 2023 07:35AM Capricor Therapeutics Announces $23 Million Registered Direct Offering
Sep 7, 2023 04:15PM Form SC 13G HH&L Acquisition Co. Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Sep 7, 2023 01:00AM Santhera Announces Half-Year 2023 Financial Results and Provides Corporate Update
Aug 15, 2023 04:31PM Form 3 HH&L Acquisition Co. For: Aug 11 Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Aug 14, 2023 03:44PM Form 13F-HR/A HIGHBRIDGE CAPITAL MANAG For: Mar 31
Aug 11, 2023 10:53AM Form 13F-HR HIGHBRIDGE CAPITAL MANAG For: Jun 30
Aug 9, 2023 04:31PM Form SC 13G/A KnightSwan Acquisition Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Jul 24, 2023 04:31PM Form 3 KnightSwan Acquisition For: Jul 20 Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Jul 19, 2023 01:00AM Santhera Announces Closing of Exclusive North America License Agreement with Catalyst Pharmaceuticals for Vamorolone
Jul 18, 2023 11:00AM CoinFund Reinforces Commitment to Web3 Technology with the Close of $158M Seed IV Fund
May 25, 2023 01:30AM Mithra - Letter to Shareholders and Corporate Update
May 15, 2023 04:31PM Form 4 ExcelFin Acquisition For: May 11 Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
May 15, 2023 04:05PM Gamida Cell Reports First Quarter 2023 Financial Results and Provides Company Update
May 11, 2023 08:01AM Form 13F-HR HIGHBRIDGE CAPITAL MANAG For: Mar 31
May 8, 2023 04:16PM Form 4 ExcelFin Acquisition For: May 04 Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Apr 28, 2023 11:40AM Press release Biocartis Group NV: Disclosure of Outstanding Voting Securities
Apr 27, 2023 01:00AM Santhera Announces Preliminary Unaudited 2022 Annual Results Ahead of Full Report Publication by End of May and Provides Corporate Update
Apr 27, 2023 01:00AM Santhera Announces Preliminary Unaudited 2022 Annual Results Ahead of Full Report Publication by End of May and Provides Corporate Update
Apr 24, 2023 04:15PM Form 3 ExcelFin Acquisition For: Apr 19 Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Mar 27, 2023 07:00AM Gamida Cell Reports Full Year 2022 Financial Results and Provides Company Update
Mar 6, 2023 09:00AM NantHealth (NH) Announces $22.5M in Funding with Highbridge and Nant Capital
Mar 6, 2023 09:00AM NantHealth Announces $22.5 Million New Financing with Highbridge and Nant Capital
Feb 28, 2023 01:00AM Santhera Secures Additional Funding Through a Private Placement of Shares and Upsizing of Existing Financing Arrangement
Feb 28, 2023 01:00AM Santhera Secures Additional Funding Through a Private Placement of Shares and Upsizing of Existing Financing Arrangement
Feb 27, 2023 04:06PM Form 3 Quotient Ltd For: Feb 16 Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Feb 21, 2023 05:03PM Form SC 13D/A Quotient Ltd Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Feb 21, 2023 11:03AM Vivo Capital Names John Massad Managing Director, Business Development
Feb 13, 2023 07:58AM Form 13F-HR HIGHBRIDGE CAPITAL MANAG For: Dec 31
Feb 10, 2023 09:51AM Form SC 13G Blockchain Coinvestors Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Feb 10, 2023 09:50AM Form SC 13G/A HYCROFT MINING HOLDING Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Feb 10, 2023 09:49AM Form SC 13G/A Clovis Oncology, Inc. Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Feb 10, 2023 09:49AM Form SC 13G/A Amryt Pharma plc Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Feb 10, 2023 09:48AM Form SC 13G/A Gamida Cell Ltd. Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Feb 10, 2023 09:47AM Form SC 13G/A LANNETT CO INC Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Feb 10, 2023 09:47AM Form SC 13G/A CompoSecure, Inc. Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
View More Recent Stories View Older Stories